Literature DB >> 9325317

Heparin/heparan sulfate (HP/HS) interacting protein (HIP) supports cell attachment and selective, high affinity binding of HP/HS.

S Liu1, D Hoke, J Julian, D D Carson.   

Abstract

Heparin/heparan sulfate (HP/HS), HS proteoglycans, and their binding proteins play important roles in a variety of biological processes. Previously, we identified a novel cell surface HP/HS interacting protein (HIP) from human uterine epithelia and a variety of other human epithelial and endothelial cells and cell lines (Liu, S., Smith, S. E., Julian, J., Rohde, L. H., Karin, N. J., and Carson, D. D. (1996) J. Biol. Chem. 271, 11817-11823; Rohde, L. H., Julian, J., Babaknia, A., and Carson, D. D. (1996) J. Biol. Chem. 271, 11824-11830). In the current studies, we have purified and characterized HIP from HEC cells, a human uterine epithelial cell line, as well as recombinant HIP from a bacterial expression system. HIP supports attachment of the human trophoblastic cell line, JAR, in a HS-dependent fashion. Predigestion of JAR cells with a mixture of heparitinases, but not chondroitinase AC, abolished cell attachment to HIP. In addition, JAR cell attachment to HIP is highly sensitive to HP inhibition and much more selective for HP/HS than other glycosaminoglycans. Dermatan sulfate displays partial inhibitory activity as well, consistent with the observation that chondroitinase ABC digestion partially reduces JAR cell attachment to HIP. Solid-phase binding assays indicate HIP binds [3H]HP with high affinity (apparent KD = 8 nM). Furthermore, HIP bound cell surface/extracellular matrix-associated HS, expressed by RL95 cells, a human uterine epithelial cell line. Anti-HIP antibody generated against a synthetic peptide derived from a putative HP/HS-binding motif resident within HIP inhibited about half of [3H]HP binding to HIP, indicating that this domain is a functional HP-binding domain of HIP. Similarly, this same synthetic peptide motif of HIP could block about 50% of [3H]HP binding to HIP; however, this peptide almost completely inhibited cell attachment to HIP, suggesting a critical role, in this regard. Collectively, these results suggest that HIP can function as a HP/HS-binding cell-cell/cell-matrix adhesion molecule.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9325317     DOI: 10.1074/jbc.272.41.25856

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Polysaccharide-poly(ethylene glycol) star copolymer as a scaffold for the production of bioactive hydrogels.

Authors:  Nori Yamaguchi; Kristi L Kiick
Journal:  Biomacromolecules       Date:  2005 Jul-Aug       Impact factor: 6.988

2.  HIP/RPL29 antagonizes VEGF and FGF2 stimulated angiogenesis by interfering with HS-dependent responses.

Authors:  Sonia D'Souza; Weidong Yang; Dario Marchetti; Caroline Muir; Mary C Farach-Carson; Daniel D Carson
Journal:  J Cell Biochem       Date:  2008-12-01       Impact factor: 4.429

3.  Heparin-mimetic sulfated peptides with modulated affinities for heparin-binding peptides and growth factors.

Authors:  Sung Hye Kim; Kristi L Kiick
Journal:  Peptides       Date:  2007-08-19       Impact factor: 3.750

Review 4.  Clinical review: anticoagulation for continuous renal replacement therapy--heparin or citrate?

Authors:  Heleen M Oudemans-van Straaten; John A Kellum; Rinaldo Bellomo
Journal:  Crit Care       Date:  2011-01-24       Impact factor: 9.097

5.  Knockdown of the Ribosomal Protein eL29 in Mammalian Cells Leads to Significant Changes in Gene Expression at the Transcription Level.

Authors:  Alexander V Gopanenko; Alena V Kolobova; Maria I Meschaninova; Alya G Venyaminova; Alexey E Tupikin; Marsel R Kabilov; Alexey A Malygin; Galina G Karpova
Journal:  Cells       Date:  2020-05-15       Impact factor: 6.600

6.  Hemostasis during low molecular weight heparin anticoagulation for continuous venovenous hemofiltration: a randomized cross-over trial comparing two hemofiltration rates.

Authors:  Heleen M Oudemans-van Straaten; Muriel van Schilfgaarde; Pascal J Molenaar; Jos Pj Wester; Anja Leyte
Journal:  Crit Care       Date:  2009-12-03       Impact factor: 9.097

7.  Endogenous ribosomal protein L29 (RPL29): a newly identified regulator of angiogenesis in mice.

Authors:  Dylan T Jones; Tanguy Lechertier; Louise E Reynolds; Richard Mitter; Stephen D Robinson; Catherine B Kirn-Safran; Kairbaan M Hodivala-Dilke
Journal:  Dis Model Mech       Date:  2012-11-01       Impact factor: 5.758

8.  Different cDNA microarray patterns of gene expression reflecting changes during metastatic progression in adenoid cystic carcinoma.

Authors:  Dan Huang; Wantao Chen; Ronggen He; Fan Yu; Zhiyuan Zhang; Weiliu Qiu
Journal:  World J Surg Oncol       Date:  2003-12-19       Impact factor: 2.754

9.  Hyperglycemia induces altered expressions of angiogenesis associated molecules in the trophoblast.

Authors:  Shu-Chun Chang; Wei-Chung Vivian Yang
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-25       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.